SCOPE AND SIGNIFICANCE
Efficient wound repair requires the coordinated effort of many different cell types. A healing wound typically goes through phases of inflammation, proliferation, and remodeling/scar formation. The first of these phases, inflammation, is an important part of the wound-healing response. Inflammatory cells, such as neutrophils (or polymorphonuclear cells) are one of the first inflammatory cells to be recruited to the site of a wound. Their primary function is to prevent infection by attacking any microbes attempting to invade the body through the open skin wound. Neutrophils produce a collection of chemical weapons used to combat microbes that includes antimicrobial peptides, reactive oxygen species, and proteases. Unfortunately, there is often collateral tissue damage associated with the release of these protective mediators. In all likelihood, this is the reason that inflammation, a relatively early event in the repair process, can have long-lasting effects that influence not only the speed of repair, but also the quality of the healed wound (e.g., the amount of scar tissue produced). This article will provide an overview of neutrophils in wound healing, emphasizing the effects of neutrophilderived proteases on wound repair.
TRANSLATIONAL RELEVANCE
As is the case with many types of inflammatory cells, there are advantages and disadvantages to eliciting a strong neutrophil response after injury. While the benefit of having a strong neutrophil response early after injury to fight off potential pathogens and reduce the chance of infection is appreciated, neutrophils can have harmful effects as well. Unfortunately, the activity of many enzymes and chemicals used by neutrophils to kill microbes is not specific to pathogens, so they can damage host tissues when released extracellularly. The multiple proteases released by neutrophils can be particularly problematic for healing wounds when extracellular levels are abnormally high. More work needs to be done to find ways of optimizing the antimicrobial effects of neutrophils while limiting the amount of tissue damage these cells cause to host tissues.
CLINICAL RELEVANCE
In a normally healing wound, a robust neutrophil response is limited to the acute wound setting. However, active neutrophils are observed for an extended period of time in chronic wounds. It has been suggested that excessive protease production by activated neutrophils can cleave growth factors and growth factor receptors causing inactivation. These proteases can also degrade the extracellular matrix to a point where it becomes an ineffective substrate for cellular migration and enlarges the area in need of repair. Ultimately, this additional tissue destruction causes persistent inflammation and more tissue damage, which then prevents the wound from progressing through the proper stages of repair. Indeed, high levels of neutrophil-derived proteases, such as serine proteases and matrix metalloproteinases (MMPs), have been reported in chronic, nonhealing wounds and active research is being conducted to assess the potential clinical value of inhibiting protease activity in chronic wounds.
DISCUSSION OF FINDINGS AND RELEVANT LITERATURE Neutrophils and wound healing
Neutrophils are part of the innate immune system, and these cells carry out a variety of functions during the normal wound repair process (Fig. 1) . Neutrophils are not frequently observed in normal skin, but they are recruited in high numbers after tissue injury (Fig. 2) . They are the first circulating inflammatory cell to move to the site of the wound, which is consistent with their primary role in defending against infection. Neutrophils produce antimicrobial substances and proteases that help kill and degrade potential pathogens, but their ability to generate multiple cytokines and growth factors allows them to do more than simply minimize Figure 1 . Overview of neutrophil activities during cutaneous repair. Circulating neutrophils are recruited to the wound site quickly after injury, where they carry out a variety of functions. They produce an array of proinflammatory mediators that recruit and activate other inflammatory cells, enhancing inflammation. In normal wounds, recruited neutrophils will eventually undergo apoptosis and be engulfed by macrophages, initiating a resolution program that terminates the inflammatory response. However, in non-healing wounds, inflammatory cells often continue to be recruited and activated, leading to persistent inflammation. Activated neutrophils help prevent wound infection by generating reactive oxygen species and producing proteases and antimicrobial peptides. These substances kill and degrade potentially pathogenic microbes, but reactive oxygen species and proteases, in particular, can cause tissue damage when released extracellularly. Excessive proteases can be especially harmful, causing unwanted degradation of the extracellular matrix and additional tissue damage. This can lead to a harmful cycle, whereby the damage caused by neutrophil-derived proteases causes even more inflammation. This leads to more tissue damage, eventually stalling the wound-healing process and preventing complete closure of the wound.
the risk of infection. In fact, studies have demonstrated that a variety of genes known to be important for wound healing are transcriptionally upregulated as neutrophils leave the bloodstream and reach the site of injury. For example, the expression of genes encoding proteins that recruit and activate more neutrophils and other inflammatory cells, promote angiogenesis, and stimulate keratinocyte and fibroblast proliferation is elevated in neutrophils that have been recruited to wounds compared to circulating neutrophils.
1 While neutrophils are an integral part of the inflammatory response and can secrete signals which amplify inflammation at the early stages of healing, recent evidence suggests that these cells also act as a signal to shut down the inflammatory phase of healing. 2 In a normally healing wound, neutrophils undergo apoptosis after performing their function at the wound site. Apoptotic neutrophils are eventually engulfed by macrophages, and the uptake of apoptotic cells by macrophages provides a strong signal for the resolution of inflammation. 3, 4 Presumably, this allows the wound to continue through the subsequent phases of healing. Therefore, continued recruitment of active neutrophils or a build up of apoptotic neutrophils due to dysregulated neutrophil apoptosis or reduced clearance by macrophages could then prolong inflammation and contribute to the development of chronic wounds. 5, 6 Thus, in addition to using their phagocytic capabilities to clear the wound of potential pathogens, neutrophils also help regulate inflammation and produce mediators that activate other cells important for the repair process. 2 Traditionally, neutrophils have been considered important for efficient wound repair. Clinical observations support this idea, as neutropenic individuals or patients with diseases characterized by defects in neutrophil trafficking or function (deficiencies in adhesion or neutrophil granules, impaired respiratory burst activity, etc.) 7 are at a higher risk for developing wound infections and often have difficulty healing wounds. 2 However, the value of having a large number of activated neutrophils in a healing wound has been heavily debated in recent years. Studies in animal models have suggested that neutrophils are dispensable for cutaneous wound repair 8 and that in wounds with a low risk of infection, neutrophils may actually impede re-epithelialization or increase scar tissue production. 9, 10 It should be noted that the percentage of circulating neutrophils in the blood differs between humans and animals like mice, which are commonly used to study wound healing. 11 In theory, these species-specific alterations could mean there are differences with regard to the importance of neutrophils in the overall healing response between humans and animals. However, the prominence of neutrophils in chronic, nonhealing human wounds is in line with animal studies linking abundant neutrophils to delayed healing and suggests that an overactive or prolonged neutrophil response can be detrimental to wound healing. 12, 13 This has led to the idea that neutrophils play dual roles in wound healing. On one hand, neutrophils can kill invading microorganisms and stimulate other immune cells to effectively eliminate threats of infection. On the Figure 2 . Neutrophil recruitment in the tissue adjacent to an acute murine skin wound. Ly-6G immunostaining is commonly used to detect tissue neutrophils (brown staining). Neutrophils are not frequently observed in normal skin of 6-week-old FVB mice (left). However, damage to the skin sets in motion a series of events causing neutrophils to travel from the bloodstream to the site of injury. This is a rapid process, and a large number of neutrophils can be seen at the wound margin, or the tissue immediately adjacent to the wound bed (WB), after injury (right). The image shows skin adjacent to a full-thickness incisional FVB mouse wound at 48 h post-injury. Open arrows are used to indicate areas heavily populated with neutrophils (brown cells). E, epidermis; D, dermis; M, muscle; WB, wound bed. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound other hand, because the activity of toxic antimicrobial substances and proteases is not specific to pathogens, neutrophil-derived mediators can cause even more damage to host tissues and potentially delay the repair process.
Neutrophil granules: a rich source of proteases
To kill and degrade potential pathogens, neutrophils are armed with a variety of antimicrobial substances and proteases. The majority of these molecules are stored in cytoplasmic granules that can either be released into phagolysosomes after a microbe has been engulfed through phagocytosis or released into the extracellular space. 2 Storage of these mediators in granules ensures that there are plenty of these proteins available and ready to be used if there is a threat of infection. Additionally, because many of these substances are nonspecific and can be toxic to the host as well as microorganisms, containment within granules also helps prevent these substances from damaging the neutrophil and host tissues. However, if neutrophils are highly stimulated or continually activated, granule contents can be released from the cell, risking unwanted damage to the extracellular matrix and surrounding host cells. The proteins contained within intracellular granules are produced at distinct stages of neutrophil development, leading to the generation of unique granule types enriched with different proteins. As a neutrophil matures in the bone marrow, it begins as an undifferentiated myeloblast with very few granules and gains a greater number of granules as it moves through the differentiation process in the bloodstream, moving from an immature promyelocyte to a segmented neutrophil (Fig. 3) . In addition to the granules containing different subsets of proteins (Table 1) , each granule type also differs in how quickly their contents can be released.
Azurophilic granules (or primary granules) are the earliest granules to form and begin to appear at the promyelocyte stage.
14 Azurophilic granules contain the highest concentrations of antimicrobial substances and are the only peroxidase-positive neutrophil granules. High levels of myeloperoxidase, an enzyme used to generate toxic reactive oxygen species, are present. In addition, azurocidin, bacterial permeability-increasing protein, lysozyme, defensins, and several serine proteases (cathepsin G, elastase, and protease 3), are found in these granules. Although azurophilic granules are the first to be synthesized, they are the last to undergo exocytosis in response to activating stimuli. For this reason, they are believed to be particularly important for intracellular killing of engulfed microbes, by fusing with and emptying their contents into the phagolysosome. 14 Specific granules (or secondary granules) are the next to form during the myelocyte and metamyelocyte stages.
14 They contain antimicrobial molecules such as the human cationic antimicrobial protein (hCAP-18; a cathelicidin family member) and lactoferrin. MMP-8 or collagenase-2, is also found in specific granules. Gelatinase granules (or tertiary granules), on the other hand, are produced during the metamyelocyte and band cell stages of neutrophil development. Like specific granules, gelatinase granules also contain some MMP-8, but they contain especially high levels of MMPs with the gelatinase activity, including MMP-2, MMP-9, and MMP-25. MMP-25 or leukolysin, is a relatively recently described membrane-bound enzyme found specifically in granulocytes. 15 It has activity against collagen IV, fibronectin, and other extracellular matrix proteins.
Secretory vesicles are sometimes classified as a fourth type of neutrophil granule. Secretory vesicles are formed in segmented neutrophils by endocytosis after the other granules are produced, and their contents can be released very quickly after stimulation.
14 This compartment contains MMP-25 as well as many receptors (i.e., integrins, growth factors, and cytokine receptors) that are translocated to the surface of the neutrophil as the vesicles fuse with the plasma membrane to release their contents. 16 
Neutrophil-derived proteases
In addition to containing an array of antimicrobial molecules, neutrophil granules are rich in proteases ( Table 1 ). The primary function of these proteases is to help kill and degrade microbes, but they can also be used by the neutrophil to degrade components of the basement membrane and extracellular matrix (Fig. 4) . This can aid in the movement of neutrophils from the circulation, into the tissue, and to the site of injury. 2, 17 Clinically, these proteases are also important because they are responsible for the added damage to host tissues caused by neutrophils when released into the extracellular space at high concentrations. Two main classes of proteases released by neutrophils are involved in wound healing: serine proteases and MMPs (Fig. 5) .
Serine proteases. Neutrophil-derived serine proteases include cathepsin G, elastase, and protease 3. All of these proteases contain a conserved histidine-aspartic acid-serine sequence in the active site, and all are stored in azurophilic granules. 18 The majority of studies on neutrophil serine proteases have focused on elastase and cathepsin G. They have similar proteolytic activities and can cleave a variety of extracellular matrix proteins, including elastin, fibronectin, laminin, vitronectin, and collagen IV. 18 Both elastase and cathepsin G are secreted at high levels by activated neutrophils early during an infection; as a result, a recent study has suggested that the activity of these proteases could be used as an early biomarker to detect wound infection. 19 Since both of these proteases are capable of degrading basement membrane proteins, it has been suggested that they could potentially interfere with re-epithelialization and the formation of a new basement membrane in the dermo-epidermal junction by keratinocytes. 20 This idea is supported by a study showing that the elastase inhibitor gramerin accelerates re-epithelialization rates. 21 In this study, inflammation was also reduced in gramerin-treated wounds, suggesting a role for elastase in the regulation of wound inflammation. 21 Similarly, high elastase levels have been observed in chronic wounds. 22, 23 Interestingly, elastase can also activate other classes of proteases (i.e., MMPs) [24] [25] [26] and inactivate protease inhibitors, 27 which could increase the total protease activity in a wound and further exacerbate host tissue damage. Elastase can also cleave and inactivate growth factors, such as hepatocyte growth factor, which becomes ineffective at stimulating keratinocyte migration after cleavage. 28 This reduction in growth factor signaling efficiency could be another reason delayed healing is observed in the presence of high elastase levels. Beneficial and detrimental effects of neutrophil-derived proteases on wound healing. Activated neutrophils produce a number of proteases that can have positive ( + ) or negative ( -) effects on the cutaneous repair process. Neutrophil-derived proteases help kill and degrade microbes and break down components of the extracellular matrix, which can debride the wound and facilitate cellular migration when present at appropriate levels. Conversely, excessive levels of proteases in the tissue resulting from overly active neutrophils or prolonged neutrophil recruitment can be detrimental by causing additional tissue damage and further inflammation. Consequently, defective collagen deposition, reduced wound strength, and delayed re-epithelialization can occur. Elastase has also been shown to be important for the antimicrobial response of neutrophils. In a porcine model, Cole et al. demonstrated that inhibition of neutrophil elastase reduced the effectiveness of bacterial clearance from wounds. 29 This was likely due to reduced activation of antimicrobial peptides when elastase activity was blocked. 29 While several studies have suggested that high levels of elastase may be damaging and reduce the efficiency of wound repair, the studies by Cole et al. demonstrate that elastase may also help prevent wound infection.
Several studies have also examined the role of cathepsin G in wound repair. In one study, incisional wounds were shown to heal with reduced wound breaking strength in cathepsin G knockout mice. 30 Wounds lacking cathepsin G also had elevated levels of myeloperoxidase and higher neutrophil numbers, suggesting that reduced degradation of neutrophil chemoattractants (tumor necrosis factor, interleukin-8, etc.) in cathepsin G knockout mice may have caused more neutrophils to populate the wound. Cathepsin G is also known to have antimicrobial effects independently of its protease activity, 31 which could be important for microbial clearance. Overall, the studies on elastase and cathepsin G suggest that high levels of neutrophil-derived serine proteases can interfere with healing, but insufficient levels could leave a wound more vulnerable to infection.
Matrix metalloproteinases. In addition to serine proteases, neutrophils also store various MMPs in their granules and secretory vesicles. MMPs are a family of enzymes that contain conserved prodomains and catalytic zinc-binding domains. 17 These proteases are stored in neutrophil granules in their latent form and must be activated after they are released by the cell. Of the MMPs present in neutrophil granules, the functions of MMP-2, MMP-8, and MMP-9 have been studied in the context of wound repair.
Several studies have examined the role of MMP-8 in wound healing. MMP-8, also known as collagenase-2, cleaves fibrillar collagen and is expressed primarily by neutrophils. In normal acute wounds, mRNA expression levels of MMP-8 are low and MMP-8 protein is primarily present in its inactive form; however, increased MMP-8 expression and high levels of active MMP-8 are associated with chronic wounds. [32] [33] [34] Two studies suggest that MMP-8 is functionally important for normal wound healing using mouse models. GutierrezFernandez et al. examined wound healing in MMP-8 knockout mice. 5 They showed a delay in wound closure in MMP-8 knockout mice and reduced neutrophil infiltration early in the repair process, suggesting that MMP-8 may aid in neutrophil trafficking. However, at later stages, they found persistent inflammation with lower levels of neutrophil apoptosis. Apoptotic neutrophils are an important signal for the resolution of inflammation, so a reduction in neutrophil apoptosis could lead to persistent inflammation. Another study used an adenoviral vector to drive MMP-8 expression in the skin, which led to impaired healing with reduced collagen deposition and breaking strength in incisional wounds. 35 The authors also observed reduced neutrophil numbers in wounds with high levels of MMP-8, which was likely due to an increase in neutrophil apoptosis.
MMP-2 and MMP-9 are also stored in neutrophil granules, although they are not as closely tied to neutrophils as MMP-8 since they are also produced by other cell types. MMP-2 and MMP-9 are gelatinase enzymes that cleave collagen IV, a primary component of basement membranes. High gelatinase activity has been described in chronic wounds, 13, 36, 37 which may be enhanced by low levels of active MMP inhibitors in these wounds. 36 MMP-2 does not appear to play a major role in the normal wound-healing process, as MMP-2-deficient mice display similar rates of wound re-epithelialization, granulation tissue formation, and collagen content. 38 However, high MMP-2 levels are found in chronic wounds. 37 MMP-9, on the other hand, is expressed at the advancing front of the wound epithelium 39 and findings from animal studies evaluating the importance of MMP-9 in wound healing have varied. In MMP-9 knockout mice, accelerated closure of both corneal and skin wounds was reported by Mohan et al., 39 while a delay in re-epithelialization and collagen organization was described by Kyriakides et al. 40 In another study, Reiss et al. showed that treatment of wounds with active MMP-9 alters the structure of the collagen IV-containing basement membrane and delays reepithelialization. 41 Like MMP-2, abundant active MMP-9 is associated with chronic wounds. 13, 37, 42 Taken together, the studies suggest that precisely balanced levels of MMP-9 may be needed for proper repair.
Counteracting protease activity: protease inhibitors
In addition to various proteases, several different protease inhibitors (Fig. 5 and Table 1 ) are stored in neutrophil granules. These inhibitors likely serve as a way to limit some of the host damage caused by neutrophil-derived proteases. Several of the protease inhibitors produced by NEUTROPHILS AND WOUND REPAIR neutrophils, such as a1-antitrypsin and secretory leukocyte protease inhibitor (SLPI), block the activity of serine proteases. Interestingly, a1-antitrypsin has been shown to be active in fluid collected from acute wounds, but is degraded in chronic wounds. 22, 43 The degradation and inactivity of a1-antitrypsin likely contributes to excessive serine protease activity in chronic wounds. SLPI is another protease inhibitor produced by neutrophils as well as epithelial cells. It counteracts the activity of elastase, but it also has antiinflammatory and antimicrobial effects. Higher levels of elastase and inflammation have been described in wounds from SLPIdeficient mice, which correlated with delayed healing. 44 In addition to neutrophils, epithelial cells are a rich source of protease inhibitors, including SLPI 44 and another protease inhibitor, a1-antichymotrypsin (a1-ACT). a1-ACT inhibits serine proteases, primarily cathepsin G, and is upregulated in keratinocytes during the repair process. 45 Treatment of diabetic wounds with a1-ACT in a mouse model was able to accelerate re-epithelialization and increase granulation tissue formation. 45 Additionally, elastase from chronic wounds was found to cleave and inactivate a1-ACT. 45 Aside from inhibiting serine protease activity, a1-ACT can also inhibit the activation of MMP-9. MMP-9 activation has been shown to be low in acute wounds due to high a1-ACT levels, whereas chronic wounds have degraded a1-ACT and high active MMP-9 levels. 46, 47 
CONCLUSIONS
While neutrophils play a key role in preventing infection, excessive neutrophil activity or the persistence of neutrophils at the wound site can contribute to the development of chronic wounds. Although some level of neutrophil-derived serine proteases and MMPs are needed for efficient microbial clearance and wound repair, data from multiple basic science and clinical studies suggest that excessive neutrophil activity can increase the amount of damage at the site of injury, leading to prolonged inflammation, further tissue damage, and ultimately, a wound that does not heal properly. The overabundance of neutrophils in chronic wounds suggests that reducing the number or limiting the activity of neutrophils may be beneficial for the treatment of recalcitrant wounds. Possible strategies for dampening the neutrophil response include neutrophil depletion or the induction of neutrophil apoptosis to reduce the overall number of wound neutrophils; however, the critical role of neutrophils in fighting infection and the difficulty of inducing apoptosis specifically in only one cell type limit the potential feasibility of these broad approaches. Because there are several proteases associated with chronic wounds for which neutrophils appear to be the primary source, neutralization of neutrophil-derived proteases may be a more useful approach to limit the harmful effects of neutrophils. Compounds that neutralize extracellular proteases, while leaving the activity of proteases contained within the neutrophil undisturbed would be ideal, sparing the ability of the neutrophil to kill microbes after they have undergone phagocytosis. Overall, the studies examining neutrophil-derived proteases and their inhibitors
TAKE-HOME MESSAGES
Neutrophils are an important part of the innate immune response in injured skin. They are among the first circulating immune cells recruited to a wound, where they defend against infection. Neutrophils produce cytokines, growth factors, and other soluble mediators that activate inflammatory cells, keratinocytes, endothelial cells, fibroblasts, and other cells present in the wound. Neutrophils also generate reactive oxygen species, antimicrobial peptides, and proteases to kill and degrade potential pathogens.
The activity of many molecules used by neutrophils to sterilize the wound is not specific to extrinsic organisms, so in addition to killing microbes, they can also target the host. Although a certain amount of protease activity is needed during wound repair, high levels of protease release by neutrophils can be harmful, causing degradation of the extracellular matrix and additional tissue damage beyond that associated with the initial injury.
Neutrophil-derived proteases are clinically significant, and have been repeatedly shown to be elevated in chronic, non-healing wounds. It is believed that a prolonged neutrophil presence and protease release causes additional tissue damage, which augments inflammation, which leads to even more protease production and further tissue damage. This creates a vicious cycle that eventually prevents the wound from healing appropriately.
It is likely that the correct balance of multiple proteases and protease inhibitors is needed to effectively clear microbes from the wound and facilitate cell migration without causing more damage to the tissue and delayed healing. Currently, it is still unclear whether measuring wound protease activity could be used clinically for early detection of wound infection, to predict healing rates, or to guide decisions for therapy. Additionally, more work will be needed to determine whether products designed to neutralize protease activity can be used to accelerate healing in chronic wounds.
suggest that tight regulation of protease activity is needed for optimal healing.
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